Toth Financial Advisory’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50
Closed -$3.05K 772
2025
Q1
$3.05K Sell
50
-2
-4% -$170 ﹤0.01% 560
2024
Q4
$4.68K Buy
52
+32
+160% +$3.76K ﹤0.01% 517
2024
Q3
$2.58K Sell
20
-40
-67% -$5.22K ﹤0.01% 573
2024
Q2
$6.81K Sell
60
-20
-25% -$2.14K ﹤0.01% 494
2024
Q1
$10.6K Hold
80
﹤0.01% 453
2023
Q4
$9.76K Buy
+80
New +$6.12K ﹤0.01% 450
2021
Q1
Sell
-3
Closed -$5K 696
2020
Q4
$5K Sell
3
-12
-80% -$19.1K ﹤0.01% 462
2020
Q3
$16K Hold
15
﹤0.01% 341
2020
Q2
$18K Buy
+15
New +$13K ﹤0.01% 293
2019
Q4
Sell
-3
Closed -$2K 506
2019
Q3
$2K Hold
3
﹤0.01% 412
2019
Q2
$3K Hold
3
﹤0.01% 394
2019
Q1
$3K Buy
+3
New +$3.12K ﹤0.01% 372

Other funds holding LABU

Toth Financial Advisory's LABU Position: Q2 2025 in Review

Toth Financial Advisory sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 50 shares — an estimated $3.05K sold.

Toth Financial Advisory first reported a position in LABU in Q1 2019 and held it in 12 quarters. The position peaked at $18K in Q2 2020. 33 funds tracked by Wall St. Rank hold LABU as of Q2 2025.

  • Toth Financial Advisory reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
  • Toth Financial Advisory sold 50 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $3.05K.
  • Toth Financial Advisory first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2019 and held it in 12 quarters.
  • Toth Financial Advisory's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $18K in Q2 2020.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.

Based on Toth Financial Advisory's 13F filing for Q2 2025, filed 14 Jul 2025.